Alfa Wassermann Separation Technologies
Christopher DeBlasis is an accomplished engineering professional with extensive experience in mechanical design and product development. Currently serving as the Director of Engineering at Alfa Wassermann Separation Technologies since September 2022, Christopher has been associated with Alfa Wassermann, Inc. since July 2014 as a Mechanical Engineer. Previous roles include Product Development and Project Engineer at Refine Technology, LLC, where expertise contributed to the ATF™ System, and Senior Mechanical Engineer at Omnyx, LLC, a leader in digital pathology solutions. Earlier positions held include Senior Mechanical Design Engineer at GE Healthcare and L & P Digital Technologies, and Physical Design Engineer at OFS/Lucent Technologies. Christopher's engineering foundation includes a Bachelor of Science in Engineering Technology from the New Jersey Institute of Technology, an Associate of Science in Mechanical Engineering Technology, and a Certificate in Drafting Technology from County College of Morris.
This person is not in any teams
Alfa Wassermann Separation Technologies
Alfa Wassermann Separation Technologies, a division of Alfa Wassermann Inc. (AWI), is the leader in ultracentrifugation solutions for process development and industrial scale manufacturing in design, manufacture and service of continuous flow ultracentrifuges. AWST ultracentrifuges are used efficiently and reliably for separation, fractionation and concentration of viral vectors, virus-like particles, viruses, viral and bacterial vaccines, macromolecules and cellular organelles for development and manufacture of vaccines and bio-products. From protocol development to pilot scale to industrial scale production, our systems meet cGMP requirements. A range of rotors allow batch and continuous flow operations with process volumes of up to two hundred liters. Scalable rotors allow protocol development with Promatix 1000™ Ultracentrifuge to be scaled-up to the KII Ultracentrifuge while retaining similar recovery and critical process parameters. With the addition of the AWST Automated Fluid Handling (AFH), customers now can have a system that fully automates and standardizes critical bio-manufacturing processes.